Genetic Testing Helps Wisconsin Man Regain Vision

Dave Seamons

Dave Seamans, photo credit: Waisman Center

 

 

Living on a big hill several miles west of Baraboo, Wisconsin, Dave Seamans loves being outdoors. Even something like chopping firewood is hardly a chore to Dave. When nightfall comes, Dave often finds himself gazing at the stars – or at least he used to, before he gradually – and inexplicably -- lost his vision over a 12-year period.

 

By 2018, Dave could barely see a pinpoint of light. He had been legally blind for three years due to optic neuropathy in both eyes. His body also felt like it was falling apart, and his unexplained collection of symptoms – including numbness in his limbs and difficulty walking – puzzled many physicians.

 

“My symptoms mocked those of someone with multiple sclerosis,” Dave says, “but I tested negative for MS.”

A 51-year-old U.S. Air Force veteran, Dave was not only depressed, but incredibly frustrated. He couldn’t get an answer to a simple question: Why is this happening?

 

“I couldn’t see. My hands and feet were going numb all the time. I needed a cane or walker and I was dropping stuff all the time,” Dave says. “I just felt like I was breaking down.”

 

Dave Meets with UW Genetic Counselor

 

 

In May 2018, thanks to a referral from his primary care doctor, Dave received genetic screening for optic neuropathy from Elizabeth Kellom, MS, CGC, a University of Wisconsin genetic counselor at the Waisman Center Medical Genetics Clinic in Madison.

 

“I took Dave’s complete medical and family history,” says Elizabeth. “I initially suspected he might have Late-onset Krabbe Disease, a rare and often deadly neurological disorder, because Dave had a niece who died of it.”

 

To determine whether Dave might have a specific type of optic neuropathy,  Elizabeth suggested that Dave undergo whole exome sequencing – a comprehensive genetic examination of his DNA, the hereditary material in humans and almost all organisms.

 

With merely a swab from the inside of his cheek (followed by a 6-week wait for results), the test would show whether any mutations, or abnormal changes, were present in Dave’s DNA that might explain his medical predicament. Insurance did not cover the test, but Dave agreed to pay for it out of pocket, which, in his case, cost more than $1,000.

 

Diagnosis confirmed: biotinidase deficiency

 

The results pointed Elizabeth in the right direction. One more enzyme test confirmed that Dave had a rare genetic disorder called biotinidase deficiency, which occurs in about 1 in 60,000 people.

 

“We all have an enzyme called biotinidase.” Elizabeth says. “It helps our bodies recycle a B-vitamin known as biotin, which we need for our metabolism to function properly. Some individuals have deficient biotinidase activity and cannot recycle biotin,” she says. “These people, if untreated, typically suffer from a variety of debilitating symptoms.”

 

Years ago -- before biotinidase deficiency was even identified -- babies who lacked biotinidase activity typically presented with severe neurological problems, including seizures and developmental delay, and sometimes eye problems and/or hearing loss,” says Elizabeth. Some of these children did not survive.

 

“Today, however,” Elizabeth says, “every baby across the country is tested for biotinidase deficiency as part of newborn screening. If a baby tests positive, he or she is given biotin supplementation, which is taken for life. If treated right away, the symptoms never even show up.”

 

Screening test didn’t exist when Dave was born

 

Dave, unfortunately, was born too early to have his condition identified in infancy. It was not until 1982 that a medical geneticist named Barry Wolf, MD, PhD, first identified biotinidase deficiency and not until a few decades later that newborns in every state were tested for it.

 

“At age 51, Dave is the oldest known living patient with biotinidase deficiency,” says Dr. Wolf, emeritus chair of Medical Genetics at Henry Ford Hospital in Detroit and currently professor of Genetics, Birth Defects and Metabolic Disease at Lurie Children’s Hospital, associated with Northwestern University Hospital in Chicago.

 

Dr. Wolf doesn’t know why Dave and his brother, Wayne – who also tested positive, but did not lose his vision – escaped the symptoms of biotinidase deficiency as children.

 

“One theory is that drinking as much milk as they did while working on a dairy farm kept the symptoms at bay for many years.”

 

Since biotin supplementation is the standard treatment for infants who test positive for biotinidase deficiency, Elizabeth – in consultation with UW medical geneticist Greg Rice, MD -- encouraged Dave to try it himself.

 

“Since Dave lived with this condition for 50 years,” Elizabeth says, “I could not promise that biotin supplementation would help him the way it helps newborns, yet I knew he had nothing to lose.”

 

In early July 2018 – just two weeks after picking up a jar of biotin at Costco -- the man who grew up staring at constellations of stars literally could not believe his own eyes.

 

A miracle: Dave sees again

 

“Before taking biotin, I might be able to see one star if I’m lucky,” Dave says. “Two weeks later, I looked up one night and saw the whole big dipper. I couldn’t stop bawling my eyes out.”

 

Dave could hardly believe what he saw, and when he told Elizabeth, she could hardly believe what she heard.

 

“The whole Genetics Department at the Waisman Center was buzzing,” she says. “In our field, a diagnosis helps people manage their condition. Rarely can we use our findings to literally change someone’s life like Dave’s.”

 

Kimberly Stepien, MD, a UW Health ophthalmologist and director of the Adult Inherited Retinal Disease Clinic, said Dave’s case beautifully illustrates the power of genetic testing.

 

“Elizabeth is the true hero in this story,” says Dr. Stepien, who was part of Dave’s care team. “She took the time to get a very thorough history and understood that we needed more than standard genetic optic neuropathy screening. Of course, Dave’s willingness to pay for the whole exome sequencing was also critical.”

 

At the same time, Dr. Stepien cautions people with poor vision not to run to the pharmacy for biotin supplements too quickly.

 

A cautionary note

 

“People can experience vision loss from a variety of conditions, including diseases such as macular degeneration or diabetic retinopathy,” she says.  “Sadly, biotin supplement is not going to help these patients.”

 

Still, she will never forget Dave Seamans and his remarkable turnaround.

 

“It was amazing to see how his visual fields, along with his other systemic symptoms, improved over the next few months after he started his supplements,” says Dr. Stepien. “It’s an ophthalmologist’s dream to help someone see again. It’s what gets us up in the morning every day.”

 

Dr. Barry Wolf, the medical genetics pioneer who first identified biotinidase deficiency 37 years ago, cherishes the friendship he has cultivated with Dave over the past two years.

 

A short, but sweet note

 

“Dave sent me a note last year that means more to me than he’ll ever know,” says Dr. Wolf. “I pull it out whenever I need a little boost.”

 

Short and sweet, Dave’s note reads as follows:

 

Dr. Wolf,

Six months ago, I was legally blind and told there was no hope. Today, for the first time in three years, I drove myself to town. I want you to know that your life's work has saved my life. For that, my family and I are eternally grateful. I hope my experience can be a part of helping others. Thank you again.


Dave Seamans

 

 


Date Published: 12/04/2019

News tag(s):  eyesophthalmology

News RSS Feed